benzonatate
- Product NDC
- 43063-799
- 11-digit product format
- 430630799
- Labeler code
- 43063
- Product ID
- 43063-799_d2bca303-1aaa-c927-e053-2995a90a02b8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- benzonatate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA040749
- Marketing category
- ANDA
- Marketing start
- 2017-03-22
- Marketing end
- 0000-00-00
- Substance
- BENZONATATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-799-01 | 43063079901 | 100 CAPSULE in 1 BOTTLE, PLASTIC (43063-799-01) | 100 capsule | 2017-10-19 | 0000-00-00 | No | No | Current |
| 43063-799-21 | 43063079921 | 21 CAPSULE in 1 BOTTLE, PLASTIC (43063-799-21) | 21 capsule | 2017-10-19 | 0000-00-00 | No | No | Current |
| 43063-799-30 | 43063079930 | 30 CAPSULE in 1 BOTTLE, PLASTIC (43063-799-30) | 30 capsule | 2017-10-19 | 0000-00-00 | No | No | Current |